This is so interesting because.... it is contray to all conventional wisdom in treating cancer, other than possibly herceptin. Shutting-off a growth factor / receptor pathway as stated in the article is would be not unlike giving aromitase inhibitors during chemo... maybe they should start thinking about multiple pathway inhibition, cox2, E, VEGF, P53, EGFR, etc. during chemo.....
Just a thought
Al
__________________
Primary care-giver to and advocate for Linda, who passed away April 27, 2006.
|